Evidence map›Paper›PMID 14662739›Full record

ArticleThe Journal of cell biology2003

IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients.

Ebru Erbay, In-Hyun Park, Paul D Nuzzi, Christopher J Schoenherr, Jie Chen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 169 citations in OpenAlex.

  1. Trial
  2. Article
  3. The role of inner nuclear membrane protein emerin in myogenesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  4. Article
  5. Article
  6. TMED10 mediates the trafficking of insulin-like growth factor 2 along the secretory pathway for myoblast differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Article
  9. Cells · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ebru ErbayDepartment of Cell and Structural Biology, University of Illinois at Urbana-Champaign, 601 S. Goodwin Ave., B107, Urbana, IL 61801, USA.
In-Hyun Park
Paul D Nuzzi
Christopher J Schoenherr
Jie Chen
University of Illinois Urbana-Champaign · US

Funding

mTOR Signaling in Skeletal MyogenesisR01AR048914 · NIAMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI CHEN, JIE · 2003 to 2019
$4.8M
FRAP AND THE RAPAMYCIN SENSITIVE SIGNALING PATHWAYR01GM058064 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI CHEN, JIE · 1999 to 2004
$1.1M
FRAP AND THE RAPAMYCIN SENSITIVE SIGNALING PATHWAYR55GM058064 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI CHEN, JIE · 1998 to 1998
–
NIAMS NIH HHS AR48914NIAMS NIH HHS R01 AR048914NIGMS NIH HHS GM58064NIGMS NIH HHS R01 GM058064
6 · The paper itself

Abstract

Insulin-like growth factors (IGFs) are essential for skeletal muscle development, regeneration, and hypertrophy. Although autocrine actions of IGF-II are known to initiate myoblast differentiation, the regulatory elements and upstream signaling pathways for myogenic expression of IGF-II remain elusive. Here, we report the regulation of IGF-II transcription by mTOR, as well as by amino acid sufficiency, through the IGF-II promoter 3 and a downstream enhancer during C2C12 myoblast differentiation. Furthermore, we present evidence that IGF production, and not IGF signaling, is the primary target for mTOR's function in the initiation of differentiation. Moreover, myogenic signaling by mTOR is independent of its kinase activity and mediated by the PI3K-Akt pathway. Our findings represent the first identification of a signaling pathway that regulates IGF-II expression in myogenesis and implicate the mTOR-IGF axis as a molecular link between nutritional levels and skeletal muscle development.

Indexed as

Gene Expression RegulationProtein Serine-Threonine KinasesTranscription, GeneticAmino AcidsAnimalsCells, CulturedEnhancer Elements, GeneticInsulin-Like Growth Factor IIMiceMuscle DevelopmentMuscle, SkeletalMyoblastsPhosphatidylinositol 3-KinasesProtein KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktAmino AcidsInsulin-Like Growth Factor IImTOR protein, mousePhosphatidylinositol 3-KinasesProtein KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktRNA, MessengerSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID14662739
PMCPMC2173600
OpenAlexW2001162357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.